BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34636292)

  • 21. Commentary: A Myriad Aberrations on Information of Ontogeny of Drug Metabolizing Enzymes in the Pediatric Population: An Obstacle for Personalizing Drug Therapy in the Pediatric Population.
    Uppugunduri CR; Ansari M
    Drug Metab Lett; 2016; 10(2):72-4. PubMed ID: 26908134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytochrome P450s: mechanisms and biological implications in drug metabolism and its interaction with oxidative stress.
    Bhattacharyya S; Sinha K; Sil PC
    Curr Drug Metab; 2014; 15(7):719-42. PubMed ID: 25429675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arylamine N-acetyltransferases and drug response.
    Meisel P
    Pharmacogenomics; 2002 May; 3(3):349-66. PubMed ID: 12052143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The biochemistry of drug metabolism--an introduction: part 5. Metabolism and bioactivity.
    Testa B; Krämer SD
    Chem Biodivers; 2009 May; 6(5):591-684. PubMed ID: 19479846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic activation of carboxylic acids.
    Skonberg C; Olsen J; Madsen KG; Hansen SH; Grillo MP
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):425-38. PubMed ID: 18433345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabonomics for discovering biomarkers of hepatotoxicity and nephrotoxicity.
    Zhang A; Sun H; Wang P; Han Y; Wang X
    Pharmazie; 2012 Feb; 67(2):99-105. PubMed ID: 22512077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unusual Biotransformation Reactions of Drugs and Drug Candidates.
    Isin EM
    Drug Metab Dispos; 2023 Apr; 51(4):413-426. PubMed ID: 36653118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism, disposition, and toxicity of drugs and other xenobiotics in aquatic species.
    Guarino AM; Lech JJ
    Vet Hum Toxicol; 1986; 28 Suppl 1():38-44. PubMed ID: 3334693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnane X receptor- and CYP3A4-humanized mouse models and their applications.
    Cheng J; Ma X; Gonzalez FJ
    Br J Pharmacol; 2011 Jun; 163(3):461-8. PubMed ID: 21091656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatopathies and drugs].
    González Macias J; De Castro del Pozo S
    Rev Esp Enferm Apar Dig; 1974; 44(2):175-86. PubMed ID: 4418081
    [No Abstract]   [Full Text] [Related]  

  • 31. Different role of biotransformation in the elimination of some important pharmaceuticals and industrial xenobiotics.
    Gut I
    Arch Toxicol Suppl; 1980; 4():350-4. PubMed ID: 6933935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [FOOD - DRUG INTERACTIONS: TYPES AND MECHANISMS.].
    Lemina EY; Churyukanov VV
    Eksp Klin Farmakol; 2016; 79(11):41-44. PubMed ID: 29791108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Many drugs and phytochemicals can be activated to biological reactive intermediates.
    Johnson WW
    Curr Drug Metab; 2008 May; 9(4):344-51. PubMed ID: 18473753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic transformation of clinically used drugs to epoxides: new perspectives in drug-drug interactions.
    Oesch F
    Biochem Pharmacol; 1976 Sep; 25(17):1935-7. PubMed ID: 985529
    [No Abstract]   [Full Text] [Related]  

  • 35. Biochemical basis for dose response relationships in reactive metabolite toxicity.
    Jollow DJ; Roberts S; Price V; Smith C
    Adv Exp Med Biol; 1981; 136 Pt A():99-113. PubMed ID: 7344497
    [No Abstract]   [Full Text] [Related]  

  • 36. Glutathione-dependent bioactivation and renal toxicity of xenobiotics.
    Dekant W
    Recent Results Cancer Res; 1997; 143():77-87. PubMed ID: 8912413
    [No Abstract]   [Full Text] [Related]  

  • 37. [Genetic significance of determined oxidation of drugs and xenobiotics in the pathogenesis of neoplastic diseases].
    Niewiński P; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 1997 Jan; 2(7):71-5. PubMed ID: 9296908
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hepatic enzyme induction through drugs].
    Estler CJ
    Fortschr Med; 1972 Apr; 90(12):452-4. PubMed ID: 4345050
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemical toxicology: reactive intermediates and their role in pharmacology and toxicology.
    Erve JC
    Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):923-46. PubMed ID: 17125409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic activation and drug toxicity.
    Nelson SD
    J Med Chem; 1982 Jul; 25(7):753-65. PubMed ID: 7050382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.